The Effective Statistician - in association with PSI

Interview with Jenny Devenport 1. Publication is a critical part of the scientific process, It is important to communicate the results Peer review still adds credibility to research Important for further steps Need to have transparency - refer to clinical trials .gov History of not publishing data in the past 2. Helps establish credibility with various stakeholders, 3. Enable scientific discussions in the field, 4. Advance science in that disease and in general A. Types of publications: Presentations Abstracts Posters (original and encore) Papers 5. Role of the statistician in an individual publication Methods characterization (to the standard of reproducibility) Results presented accurately and in a balanced manner Clinical and statistical conclusions are consistent and more... Listen to this episode and share this with your friends and colleagues!

Why does CONSORT not fit with a secondary paper? Tell a good story Make the story aligned with the overall strategy The 3 times 3 rule for a good paper The importance of good graphics Why do non-standard analyses help often Leveraging the appendix Further use of the paper Connection to abstracts and posters Working with co-authors Listen to this episode and share this with your friends and colleagues!

Reasons for staying comfortable Fear of rejection Fear of failure Fear of not meeting expectations Unfair comparison to others Not being ready Being too busy Not important Set systems to reach your goals You can reach incredible goals Do something different Grow personally Vulnerability Innovation

Interview with Claude Petit We talked about the following points: What got you interested in leadership? What means leadership to you? Why is leadership important for us statisticians? What would a statistics organisation look like, if it would be very strong in leadership? How can we build such an organisation of statistical leaders? What's your #1 tip to become a statistical leader?

Interview with Sree Kurup In this episode, we talked about the following points: What is the role of a pharmacometrician in the development of drugs? Besides statistics - what other functions do pharmacometricians work closely together with? Where are the touchpoints of pharmacometricians and statisticians? What is your experience of how both functions can work best together? and more…

Some of the input data is missing for some studies. How do you deal with these missings - just exclude them? You compare many treatments with each other in a pairwise way. How do you best communicate this large matrix of pairwise comparisons? You need to adapt your NMA last minute because there was a delay in the system and your systematic literature search became outdated. Do you need to postpone the launch of the new product by a couple of weeks? You got regulatory approval for a new indication earlier than expected. While the regulatory team celebrates the achievement you worry that you need to have your NMA ready 3 months earlier. Will you be able to deliver? We discuss these and many more problems of NMAs. If you would like to get help around these, write an email to alexander@theeffectivestatistician.com or contact me via LinkedIn.

with Jenny Devenport Why do non-statisticians need training in what they're interested in and why do they need to understand statistics? Why is a multi-channel approach really needed? What can we learn about the importance of the interactions between statistician trainers and non-statistician trainees? When conducting training, how must we decide what topics to cover by including what questions to ask? Listen to this episode and share this with your friends and colleagues!

Webinar with Emma Adams Listen to this webinar while Emma and I talk about exploring the resulting recruitment challenges in a post-pandemic world within Life Sciences as a sector, also specifically within statistics across the UK and Europe. We confront recruitment challenges, as well as taking a thorough analysis into what Statisticians want—how to hire and how to keep top talent.  

Interview with Anders Berglund ``` We discuss the following points: What brought Anders into RWE What makes Nordic countries special when it comes to health system? What are some key success factors of the Nordic health system? What kind of population registers are there? and more… Reference: Epistat Nordic Registries ```

Interview with Heather Melius We also talk about the following points: How have you learned about the concept of your personal board of directors?Why should we have one?What worked and didn’t work as you built your own board?Do you have an example of where this board helped you?How does it evolve over time? References: 4 Steps to build your personal directorsEveryone needs a personal board of directorsPersonal board of directors Listen to this episode and share this with your friends and colleagues who might learn from it!